JCR Pharmaceuticals Co Ltd (4552.T)
16 Mar 2018
Get access to over 18 million research reports from over 1,700 sources.
For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.
Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.
Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:
- private equity
- third-party document and information retrieval
- and much, much more…
Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.
|70||2007||Chairman of the Board, President, Chief Executive Officer, Chief Operating Officer, Chairman of Subsidiary, Representative Director|
|58||2014||Vice President, Representative Director|
|64||2016||Senior Managing Director|
|2016||Executive Officer, Chief Director of Sales, Director of Eastern Japan Sales|
- BRIEF-Sumitomo Dainippon Pharma and JCR Pharmaceuticals sign license agreement
- BRIEF-JR-131, long-acting erythropoiesis-stimulating agent, demonstrates equivalence in phase III study
- BRIEF-Medipal Holdings signs contract to set up JV JCR USA with JCR Pharmaceuticals
- BRIEF-JCR Pharmaceuticals to initiate development of JR-171, new drug candidate for Hurler Syndrome using J-Brain Cargo
- BRIEF-NanoCarrier and JCR conclude collaborative research agreement for drug delivery to the brain for nucleic acid medicines